Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO BIO.B · Entity 2247 | EVP, Global Human Resources | September 05, 2025 | September 09, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date September 05, 2025 · Filed September 09, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 19,550 |
Ending reported balance
After 2025-09-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-06 · Exercise / conversion · Acquired 576 · Balance 19,759 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. Row 2 · 2025-09-06 · Tax withholding · Disposed 209 · Balance 19,550 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,740 |
Reported balance
After 2025-09-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-09-05 · Grant · Acquired 2,740 · Balance 2,740 F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,728 |
Reported balance
After 2025-09-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-09-06 · Exercise / conversion · Disposed 576 · Balance 1,728 F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 576 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · derivative · entry 4 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728 Underlying: Bio-Rad A Common Stock · 576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 209 | $295.43 | $61,744.87 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · nonDerivative · entry 2 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,550 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · nonDerivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 2,740 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · derivative · entry 3 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,740 Underlying: Bio-Rad A Common Stock · 2,740 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 501 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · derivative · entry 5 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,002 Underlying: Bio-Rad A Common Stock · 501 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 347 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · derivative · entry 4 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347 Underlying: Bio-Rad A Common Stock · 347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · derivative · entry 3 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 398 | $297.88 | $118,556.24 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · nonDerivative · entry 2 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,183 Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · nonDerivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,946 | $0.00 Strike: $256.45 | $0.00 |
DisclosureSEC source: 0001062993-25-004593 · form4.xml · derivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,946 Underlying: Bio-Rad A Common Stock · 1,946 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 18:01 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 2,304 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016382 · form4.xml · derivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304 Underlying: Bio-Rad A Common Stock · 2,304 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 15 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 177 | $334.31 | $59,172.87 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 10 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,479 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 9 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 14 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 129 | $337.32 | $43,514.28 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 8 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,161 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 7 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 253 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 13 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: Bio-Rad A Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 347 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 12 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694 Underlying: Bio-Rad A Common Stock · 347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 11 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,503 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 91 | $337.32 | $30,696.12 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 6 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,929 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 5 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 124 | $337.32 | $41,827.68 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 4 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,767 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 347 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 3 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 179 | $337.32 | $60,380.28 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 2 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,544 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 16:28 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,357 | $0.00 Strike: $343.76 | $0.00 |
DisclosureSEC source: 0001062993-24-006219 · form4.xml · derivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,357 Underlying: Bio-Rad A Common Stock · 2,357 shares Expires 2034-03-08 F1 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 16 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 208 | $394.60 | $82,076.80 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 10 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,223 Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 9 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 15 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495 Underlying: Bio-Rad A Common Stock · 495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 172 | $394.60 | $67,871.20 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 8 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,831 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 7 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 14 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361 Underlying: Bio-Rad A Common Stock · 361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 125 | $394.60 | $49,325.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 6 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,508 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 5 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 253 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 13 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507 Underlying: Bio-Rad A Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 347 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 12 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,041 Underlying: Bio-Rad A Common Stock · 347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 2,003 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · derivative · entry 11 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,003 Underlying: Bio-Rad A Common Stock · 2,003 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 88 | $394.60 | $34,724.80 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 4 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,272 Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 3 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 120 | $394.60 | $47,352.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 2 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,107 Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:52 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 347 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017636 · form4.xml · nonDerivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.